✦ LIBER ✦

Significant improvement of response rate and survival with cisplatin, epirubicin, 5-fluorouracil and gemcitabine (PEF-G regimen) in metastatic pancreatic cancer

✍ Scribed by M. Reni; A.J.M. Ferreri; M.G. Panucci; S. Cordio; U. Scaglietti; G.L. Ceresoli; G. Bordogna; M. Garassino; E. Villa

Book ID: 117667519
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 154 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(99)80975-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of continuous infusion

A phase II study of continuous infusion 5-fluorouracil (5-FU) with epirubicin and cisplatin in metastatic, hormone-resistant prostate cancer: an active new regimen

✍ D Chao; M von Schlippe; S.J Harland 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 453 KB

Response rates and survival in patients

Response rates and survival in patients with head and neck cancer treated with a combination of cisplatin and 5-fluorouracil prior to radiotherapy

✍ G.D. Thomas; I.C.M. Paterson 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 431 KB

High rate of clinical complete response

High rate of clinical complete response to weekly outpatient chemotherapy in oral carcinoma patients using a new regimen of cisplatin, 5-fluorouracil, and bleomycin alternating with methotrexate and epirubicin

📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 128 KB

High rate of clinical complete response

High rate of clinical complete response to weekly outpatient neoadjuvant chemotherapy in oral carcinoma patients using a new regimen of cisplatin, 5-fluorouracil, and bleomycin alternating with methotrexate and epirubicin

✍ Jin-Ching Lin; Jian-Sheng Jan; Chen-Yi Hsu; Daniel Yong-Kie Wong 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 2 views

A Phase II trial was initiated to evaluate the response to and toxicity of a new regimen of weekly outpatient neoadjuvant chemotherapy in patients with oral carcinoma. ## METHODS. Patients with previously untreated squamous cell carcinoma of the oral cavity were eligible for this trial. The neoad

785 PUBLICATION Weekly regimen of cispla

785 PUBLICATION Weekly regimen of cisplatin (CDDP), epirubicin(EPI), fluorouracil (5FU) and folinic acid (FA) with G-CSF is active in advanced gastroesophageal(GE) and gastric(G) cancer: results of a phase II study

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB